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Abstract
Introduction: We investigated the inflammatory potential of O-linked N-acetylglucosamine glycosylation (O-
GlcNAcylation) of p65 in rheumatoid arthritis (RA).
Methods: Fibroblast-like synoviocytes (FLS) and MH7A cells were treated with synthetic ThiaMet-G (200 μM), an
O-GlcNAcase (OGA) inhibitor, followed by tumor necrosis factor (TNF)-α (10 μg/mL). Proliferation of synovial cells
was measured by MTT assay, and the levels of mRNAs encoding pro-inflammatory molecules were quantitated by
RT-PCR. The nuclear localization of O-GlcNAcylated of p65 and its DNA binding affinity and transcriptional activity
were assessed. The severity assessment of arthritis and a histopathological examination were done in mice with
collagen induced arthritis (CIA). ThiaMet-G (20 mg/kg) intraperitoneal injection was done every other day for 26
days. Fluorescence-activated cell sorting (FACS) analysis of T cells was performed.
Results: Hyper-O-GlcNAcylation increased the proliferation and mRNA expression of pro-inflammatory genes in
synoviocytes stimulated by TNF-α. Moreover, O-GlcNAcylation of p65 enhanced its proportion of nuclear localization,
DNA binding affinity and transcriptional activity. In CIA mice, ThiaMet-G significantly aggravated the severity of arthritis
clinically and histologically, and it also increased CD4 + IFN-γ + T cells and CD4 + IL-17+ T cells.
Conclusions: O-GlcNAcylation of p65 increased the effects of TNF-α-mediated inflammation both in vitro (in synovial
cells) and in vivo (in mice with CIA).
Introduction
O-linked N-acetylglucosamine (O-GlcNAc) glycosylation
(O-GlcNAcylation) is a distinct form of glycosylation,
which occurs in both the nucleus and the cytoplasm, un-
like other forms of glycosylation, which are exclusive to
either the endoplasmic reticulum or the Golgi complex
[1]. O-GlcNAcylation of serine or threonine residues is
mediated by O-GlcNAc transferase (OGT) and it is re-
moved by O-GlcNAcase (OGA) under tightly regulated
conditions [1]. O-GlcNAcylation affects numerous cellular
processes, including embryonic development, basal me-
tabolism, and tuning of the circadian clock, as well as im-
mune responses in both cancer and inflammatory diseases
[2–5]. Recently, O-GlcNAcylation of nuclear factor-kappa
B (NF-κB) has attracted considerable attention, because of
the reciprocal effects evident in different cell types, includ-
ing positive regulation of pancreatic cancer cells and nega-
tive regulation of aortic smooth muscle cells [6–8].
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Rheumatoid arthritis (RA) is an autoimmune disease
characterized by inflammation and destruction of joint
tissues [9]. As NF-κB acts as a pivotal regulator of pro-
inflammatory molecules, such as tumor necrosis factor
(TNF)-α and interleukin (IL)-6, in the pathogenesis of
RA [9, 10], we hypothesized that O-GlcNAcylation of
NF-κB might affect the course of RA. Here, we exam-
ined the inflammatory potential of O-GlcNAcylation of
p65, a subunit of NF-κB, in RA. In vitro analyses were
performed on fibroblast-like synoviocytes (FLS) and
MH7A cells, followed by in vivo analyses using a mouse
model of collagen-induced arthritis (CIA).
Materials and methods
Synoviocyte preparation and treatment
This study was approved by the Institutional Review
Board of Severance Hospital (4-2012-0733). Informed
consent was obtained from RA patients providing synovial
tissues. FLS and MH7A cells were cultured as described
previously [11, 12]. FLS and MH7A cells were treated with
synthetic ThiaMet-G (200 μM), an OGA inhibitor, for 6 h,
followed by TNF-α (10 μg/mL) for 12 h [13]. We synthe-
sized ThiaMet-G according to a method for its synthesis
provided by Prof. Vodadlo DJ (Simon Fraser University,
Canada). The proliferation/viability of FLS and MH7A
was measured by MTTassay.
Overexpression and small hairpin RNA (shRNA)-mediated
knockdown of OGA
The human OGA gene was cloned into a pRK5-FLAG vec-
tor (Genentech Inc., USA) and transiently transfected into
MH7A cells using Lipofectamine 2000 (Invitrogen, USA).
The pLKO.1 vector and packaging plasmid pMD.2G-VSVG
and PsPax2 were used to generate a lentivirus-based OGA
shRNA construct, as described previously [14]. This proto-
col is available on the website [15].
RT-PCR
The levels of mRNAs encoding pro-inflammatory mole-
cules were quantitated by RT-PCR. All experiments were
performed in triplicate using a 7300 RT-PCR System
(Applied Biosystems, USA) and a SYBR Green kit (Takara,
Japan). A full list of primers is available in Additional file 1.
Western blotting and succinylated wheat germ agglutinin
(sWGA)-affinity purification
Western blotting immunoprecipitation was performed
using anti-p65 (Santa Cruz Biotechnology, USA) and anti-
O-GlcNAc (Covance, USA) and succinylated wheat germ
agglutinin (sWGA)-affinity purification were performed
for precipitating the O-GlcNAcylated proteins [16].
Measurement of DNA binding affinity and transcriptional
activity of p65
Avidin-biotin complex DNA (ABCD) lysis buffer con-
taining 10 mM Tric-Cl (pH 7.4), 150 mM NaCl, 1 mM
EDTA and 0.2 % Nonidet P-40 with protease inhibitor
cocktail was used for MH7A cells lysis to measure DNA
binding affinity. Lysates were incubated with biotinylated
NF-κB promoter site DNA and streptavidin beads,
washed three times in ABCD lysis buffer, and eluted in
SDS sample buffer. NF-κB transcriptional activity was
measured in MH7A cells transfected with NF-κB-
dependent luciferase reporter gene construct 4xkB- Luc.
Reporter gene assays were performed using the Dual-
Luciferase kit (Promega, USA), with firefly luciferase ac-
tivity normalized to renillia luciferase activity.
Mice with CIA
We evenly divided 30 male DBA/1 mice at 8 weeks of age
(SLC, Shizoka, Japan) into three groups (group 1, controls;
group 2, untreated; group 3, ThiaMet-G-treated). We
established a CIA model and assessed its severity clinically
(arthritis score and paw thickness) and histologically (syn-
ovial proliferation, bone destruction and inflammatory cell
infiltration under hematoxylin and eosin stain), as described
previously [17]. Two weeks after primary immunization,
mice were treated with 20 mg/kg ThiaMet-G via intraperi-
toneal (IP) injection, every other day for 26 days [18]. Con-
trols and untreated mice were injected IP with the same
volume of PBS every other day during the ThiaMet-G treat-
ment period. Mice were next sacrificed and immune cells
isolated from the spleen; T cells were then isolated and ana-
lyzed using fluorescence-activated cell sorting (FACS)
[19]. The experimental protocols were approved by the In-
stitutional Animal Care and Use Committee of Yonsei
University College of Medicine.
Statistical analyses
Each experiment was performed in triplicate, and re-
peated three to four times. All of the analyses were con-
ducted using the SPSS package for Windows version
20.0 (SPSS Inc., Chicago, IL, USA). Data are representa-
tive of the mean values obtained. Differences between
groups were evaluated using the Mann–Whitney U test.
Multiple-group comparisons were performed using ana-
lysis of variance followed by application of Tukey’s
method for multiple comparisons. P values <0.05 were
considered to indicate statistical significance for all stat-
istical evaluations.
Results
The effect of Hyper-O-GlcNAcylation on FLS growth
TNF-α significantly increased proliferation of FLS, com-
pared to controls, and proliferation was further en-
hanced following treatment with ThiaMet-G (Fig. 1a).
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Fig. 1 Effects of O-linked N-acetylglucosamine glycosylation on proliferation and gene expression in synovial cells. Fibroblast-like synoviocytes
(FLS) and MH7A cells were treated with synthetic ThiaMet-G (200 μM) for 6 h, an O-GlcNAcase (OGA) inhibitor, followed by TNF-α (10 μg/mL)
for 12 h. Proliferation of synovial cells was measured by MTT assay. a TNF-α significantly increased proliferation of FLS, compared to controls
and proliferation was further enhanced following treatment with ThiaMet-G. b The human OGA gene was cloned into a pRK5-FLAG vector
and transiently transfected into MH7A cells. In contrast to treatment of ThiaMet-G, overexpression of OGA in FLS significantly attenuated the
effects of TNF-α on proliferation, compared to controls. c The levels of mRNAs encoding pro-inflammatory molecules including matrix
metalloproteinase-1 (MMP-1), chemokine ligand 5 (CCL5) and IL-8, were quantitated by RT-PCR. ThiaMet-G did not affect the expression levels
of pro-inflammatory molecules. But, ThiaMet-G significantly increased expression levels in TNF-α-stimulated FLS, compared to untreated
controls. d The pLKO.1 vector and packaging plasmid pMD.2G-VSVG were used to generate a lentivirus-based OGA shRNA construct. OGA
shRNA significantly decreased the expression of OGA by about 75 %, compared to sh-luciferase (sh-Luc) control. Similar effects were seen
following shRNA-mediated knockdown of OGA, resulting in substantial increase in IL-6 expression, compared to those of sh-Luc controls in
TNF-α-stimulated MH7A cells (*P <0.05). GAPDH glyceraldehyde-3-phosphate dehydrogenase
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Fig. 2 (See legend on next page.)
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Similar effects were also evident following treatment with
NButGT, another OGA inhibitor, in TNF-α-stimulated
FLS (Additional file 2). In contrast, overexpression of
OGA in FLS significantly attenuated the effects of TNF-α
on proliferation, compared to controls (Fig. 1b).
The effect of hyper-O-GlcNAcylation on pro-inflammatory
gene expression
ThiaMet-G did not affect the expression levels of pro-
inflammatory molecules, including IL-6, matrix metall
oproteinase-1 (MMP-1), chemokine ligand 5 (CCL5) and
IL-8 in unstimulated FLS [11]. However, ThiaMet-G sig-
nificantly increased expression levels in TNF-α-stimulated
FLS, compared to untreated controls (Fig. 1c). OGA
shRNA significantly decreased the expression of OGA by
about 75 %, compared to sh-Luc control. And similar ef-
fects were seen following shRNA-mediated knockdown of
OGA, resulting in substantial increase in IL-6 expression,
compared to those of sh-luciferase (sh-Luc) controls in
TNF-α-stimulated MH7A cells (Fig. 1d).
The effect of O-GlcNAcylation of p65 on nuclear
localization, DNA binding affinity and transcriptional
activity of p65
We confirmed that O-GlcNAcylation of p65 was enhanced
by ThiaMet-G in MH7A cells using western blotting im-
munoprecipitation with both anti-p65 and anti-O-GlcNAc
(Fig. 2a). ThiaMet-G significantly increased the nuclear
translocation of p65 in TNF-α-simulated MH7A cells
within 1 h (Fig. 2b). TNF-α-simulated MH7A cells exhib-
ited significant increases in both the DNA binding affinity
and transcriptional activity of p65, compared to controls
and these effects were further enhanced following treat-
ment with ThiaMet-G (Fig. 2c and d). Moreover, TNF-α
alone augmented the level of O-GlcNAcylated p65 in FLS
lysates (Fig. 2e).
The effect of hyper-O-GlcNAcylation on the severity of
arthritis in mice with CIA
ThiaMet-G significantly aggravated the severity of arth-
ritis in CIA mice, compared to untreated mice with CIA
(Fig. 3a). Histopathological evaluation of joint sections
revealed that synovial proliferation and bone destruction,
but not inflammatory cell infiltration, were more severe in
ThiaMet-G-treated mice than untreated mice with CIA
(Fig. 3b). On western blotting with anti-O-GlcNAc,
ThiaMet-G remarkably enhanced the level of cellular O-
GlcNAcylation in splenocytes of mice with CIA (Additional
file 3). ThiaMet-G significantly increased the numbers of
CD4+ IFN-γ+ T cells (8.5 % vs 6.8 %) and CD4+ IL-
17+ T cells (17.0 % vs 14.3 %), but not CD4+ IL-4+ T
cells or CD4+ FoxP3+ T cells, in treated compared to
untreated mice with CIA, respectively (Fig. 3c). Our data
suggested that hyper-O-GlcNAcylation by ThiaMet-G might
drive T cell populations into T helper (Th)1 and Th17 cells,
which play a pivotal role in the pathogenesis of RA.
Discussion
We showed that hyper-O-GlcNAcylation accelerated the
inflammatory responses of synoviocytes in vitro and CIA
mice in vivo. Hyper-O-GlcNAcylation increased both cell
proliferation and the expression levels of pro-inflammatory
cytokines associated with RA in TNF-α-stimulated FLS. In
contrast, hypo-O-GlcNAcylation in response to OGA
overexpression significantly attenuated inflammation in
TNF-α-stimulated FLS. Furthermore, we found that O-
GlcNAcylation of p65 enhanced inflammatory processes in
TNF-α-stimulated FLS via increased nuclear translocation
of p65, DNA binding of the protein, and enhanced tran-
scriptional activity, increasing the expression levels of
downstream genes. Interestingly, TNF-α per se increased
O-GlcNAcylation of p65 in the absence of OGA inhibitors,
which may suggest that autocrine stimulation perpetuates
inflammation in some patients.
In an animal model of RA, hyper-O-GlcNAcylation
upon ThiaMet-G treatment significantly aggravated the
severity of arthritis. In addition, hyper-O-GlcNAcylation
increased the proportions of both Th1 and Th17 cells in
mice with CIA, compared to untreated mice with CIA.
Considering the therapeutic efficacy of p65 inhibitors in
mice with CIA, and the ability of p65 to induce rear-
rangements in pro-inflammatory T cells [19, 20], data
suggested that O-GlcNAcylation of p65 may exacerbate
arthritis severity in part via driving T cell populations
into Th1 and Th17 cells, which play a pivotal role in the
pathogenesis of RA.
(See figure on previous page.)
Fig. 2 Nuclear localization, DNA binding affinity and transcriptional activity of O-linked N-acetylglucosamine glycosylated (O-GlcNAcylated) p65.
a We confirmed that O-GlcNAcylation of p65 was enhanced by ThiaMet-G in MH7A cells using western blotting immunoprecipitation with
both anti-p65 and anti-O-GlcNAc. b Western blotting (WB) was performed using anti-p65 and anti-O-GlcNAc and succinylated wheat germ
agglutinin (sWGA)-affinity purification were performed for precipitating the O-GlcNAcylated proteins. ThiaMet-G significantly increased the
nuclear translocation of p65 in TNF-α-simulated MH7A cells within 1 h. c and d Avidin-biotin complex DNA (ABCD) lysis buffer was used for
MH7A cells lysis to measure DNA binding affinity. Lysates were incubated with biotinylated nuclear factor-kappa B (NF-κB) promoter site DNA.
NF-κB transcriptional activity was measured in MH7A cells transfected with NF-κB-dependent luciferase reporter gene construct 4xkB- Luc.
TNF-α-simulated MH7A cells exhibited significant increases in both the DNA binding affinity and transcriptional activity of p65, compared to
controls and these effects were further enhanced following treatment with ThiaMet-G. e TNF-α alone augmented the level of O-GlcNAcylated
p65 in fibroblast-like synoviocyte lysates. (*P <0.05)
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O-GlcNAc modification is often suggested to serve as
a nutrient sensor, being more common in hyperglycemic
conditions (diabetes mellitus and metabolic syndrome).
Here, we focused on the role of O-GlcNAcylation in RA,
although any direct correlation between hyperglycemia
and RA disease activity has yet to be elucidated. We
studied local joint hypoxia rather than systemic glycemic
conditions, because uncontrolled synovial hyperplasia
triggered by various pro-inflammatory cytokines may in-
duce local hypoxia-like cancers, which in turn may trig-
ger hyper-O-GlcNAcylation [21].
With these results, we might carefully suggest a hypoth-
esis on the association between hyper-O-GlcNAcylation
or O-GlcNAcylation of p65 and the aggravated severity of
arthritis as follows: (i) upon initiation of RA, hyperplasia
of the synovium may create localized hypoxia; (ii) in turn
there might be a status of hyper-O-GlcNAcylation includ-
ing p65; (iii) these effects are further exacerbated by TNF-
α per se, increasing O-GlcNAcylation of p65 further; (iv)
O-GlcNAcylation of p65 enhances nuclear translocation
and transcriptional activation, increasing the expression
levels of pro-inflammatory molecules; (v) these pro-
inflammatory molecules augment the synovial inflamma-
tion, thereby enhancing T cell-mediated inflammation,
resulting in RA aggravation quite apart from the effects of
O-GlcNAcylation of p65 (Additional file 4).
We had several limitations in our pilot study. We did
not explore the effects of O-GlcNAcylation on other
kinases and transcriptional factors involved in RA
pathogenesis and we did not use the minimal dose of
ThiaMet-G for cultured cells. We used the relatively
high concentration of ThiaMet-G to investigate the
effect of ThiaMet-G treatment in TNF-α-stimulated
synovial cells. A future study including such work will
improve our understanding of O-GlcNAc-mediated
inflammation, but data presented here provide valuable
evidence for a role of p65 O-GlcNAcylation of p65 in RA.
Conclusion
We herein showed that O-GlcNAcylation of p65 in-
creased the effects of TNF-α-mediated inflammation
both in vitro (in synovial cells) and in vivo (in mice with
CIA). We believe that our study may serve as a starting
point for future investigations into the role played by
O-GlcNAcylation in RA.
Additional files
Additional file 1: Primers for RT-PCR. A full list of primers for
inflammatory molecules used in RT-PCR. (DOC 30 kb)
Additional file 2: MTT assay. TNF-α (10 μg/mL) significantly increased
proliferation of fibroblast-like synoviocytes (FLS), compared to controls
and proliferation was further enhanced following treatment with by
NButGT (50 μM, for 24 h). (JPEG 79 kb)
Additional file 3: ThiaMet-G-treated splenocytes. ThiaMet-G remarkably
enhanced the level of cellular O-GlcNAcylation level in splenocytes of mice
with collagen-induced arthritis on western blotting with anti-O-GlcNAc.
(JPEG 102 kb)
Additional file 4: Hypothesis of the link between hyper- O-
GlcNAcylation and the aggravation in arthritis severity. (i) Upon
initiation of rheumatoid arthritis, hyperplasia of the synovium may create
localized hypoxia; (ii) in turn there might be a status of hyper-O-
GlcNAcylation including p65; (iii) these effects are further exacerbated
by TNF-α per se, increasing O-GlcNAcylation of p65 further; (iv)
O-GlcNAcylation of p65 enhances nuclear translocation and transcriptional
activation, increasing the expression levels of pro-inflammatory molecules;
(v) these pro-inflammatory molecules augment the synovial inflammation,
thereby enhancing T cell-mediated inflammation, resulting in aggravation of
rheumatoid arthritis quite apart from the effects of O-GlcNAcylation of p65.
(JPEG 276 kb)
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